SIMILAR PATTERNS OF AMINO ACIDS FOR 5TEG_B_SAMB401
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1mvh | CRYPTIC LOCIREGULATOR 4 (Schizosaccharomycespombe) |
PF00856(SET)PF05033(Pre-SET) | 5 | LYS A 338GLY A 339TYR A 381ASN A 409HIS A 410 | None | 1.00A | 5tegB-1mvhA:11.75tegE-1mvhA:undetectable | 5tegB-1mvhA:21.075tegE-1mvhA:4.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1peg | HISTONE H3METHYLTRANSFERASEDIM-5 (Neurosporacrassa) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 160TYR A 204ASN A 241HIS A 242TYR A 283 | SAH A 319 ( 4.6A)SAH A 319 (-4.0A)SAH A 319 (-3.6A)SAH A 319 (-4.3A)SAH A 319 (-4.7A) | 0.35A | 5tegB-1pegA:13.15tegE-1pegA:undetectable | 5tegB-1pegA:22.705tegE-1pegA:13.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2h21 | RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE (Pisum sativum) |
PF00856(SET)PF09273(Rubis-subs-bind) | 5 | GLY A 81LEU A 240ASN A 242HIS A 243TYR A 287 | SAM A 801 (-3.7A)NoneSAM A 801 (-2.9A)SAM A 801 (-4.9A)SAM A 801 (-4.8A) | 0.33A | 5tegB-2h21A:6.15tegE-2h21A:undetectable | 5tegB-2h21A:19.735tegE-2h21A:6.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 151TYR A 193ASN A 219HIS A 220TYR A 261 | SAM A 304 (-3.5A)SAM A 304 (-4.2A)SAM A 304 (-3.3A)SAM A 304 (-4.9A)SAM A 304 (-4.9A) | 0.35A | 5tegB-2r3aA:12.65tegE-2r3aA:undetectable | 5tegB-2r3aA:23.785tegE-2r3aA:26.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2w5z | HISTONE-LYSINEN-METHYLTRANSFERASEHRX (Homo sapiens) |
PF00856(SET) | 5 | GLY A3840ARG A3841TYR A3883ASN A3906HIS A3907 | SAH A4971 ( 3.7A)NoneNoneSAH A4971 (-3.1A)SAH A4971 (-4.7A) | 0.86A | 5tegB-2w5zA:15.75tegE-2w5zA:undetectable | 5tegB-2w5zA:30.965tegE-2w5zA:4.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2w5z | HISTONE-LYSINEN-METHYLTRANSFERASEHRX (Homo sapiens) |
PF00856(SET) | 5 | GLY A3840TYR A3883ASN A3906HIS A3907TYR A3944 | SAH A4971 ( 3.7A)NoneSAH A4971 (-3.1A)SAH A4971 (-4.7A)SAH A4971 (-4.9A) | 0.69A | 5tegB-2w5zA:15.75tegE-2w5zA:undetectable | 5tegB-2w5zA:30.965tegE-2w5zA:4.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 6 | LYS A 135GLY A 136TYR A 178ASN A 209HIS A 210TYR A 248 | NoneSAH A 305 (-3.8A)SAH A 305 (-4.0A)SAH A 305 (-3.4A)NoneSAH A 305 (-4.9A) | 0.35A | 5tegB-3bo5A:13.35tegE-3bo5A:undetectable | 5tegB-3bo5A:22.415tegE-3bo5A:5.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | LYS A 135LEU A 139ASN A 209HIS A 210TYR A 248 | NoneNoneSAH A 305 (-3.4A)NoneSAH A 305 (-4.9A) | 1.46A | 5tegB-3bo5A:13.35tegE-3bo5A:undetectable | 5tegB-3bo5A:22.415tegE-3bo5A:5.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cbo | HISTONE-LYSINEN-METHYLTRANSFERASESETD7 (Homo sapiens) |
PF00856(SET) | 5 | GLY A 227ASN A 296HIS A 297TYR A 335TRP A 352 | SAH A 1 ( 4.0A)SAH A 1 (-3.3A)NoneSAH A 1 (-4.9A)SAH A 1 (-3.9A) | 0.89A | 5tegB-3cboA:13.05tegE-3cboA:undetectable | 5tegB-3cboA:24.805tegE-3cboA:3.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cbo | HISTONE-LYSINEN-METHYLTRANSFERASESETD7 (Homo sapiens) |
PF00856(SET) | 5 | LEU A 230ASN A 296HIS A 297TYR A 335TRP A 352 | NoneSAH A 1 (-3.3A)NoneSAH A 1 (-4.9A)SAH A 1 (-3.9A) | 1.39A | 5tegB-3cboA:13.05tegE-3cboA:undetectable | 5tegB-3cboA:24.805tegE-3cboA:3.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Mus musculus) |
PF00856(SET)PF01753(zf-MYND) | 6 | GLY A 18ARG A 19LEU A 203ASN A 205HIS A 206TYR A 252 | SFG A 491 ( 4.2A)SFG A 491 (-3.9A)NoneSFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) | 0.51A | 5tegB-3n71A:7.85tegE-3n71A:undetectable | 5tegB-3n71A:15.045tegE-3n71A:8.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Mus musculus) |
PF00856(SET)PF01753(zf-MYND) | 6 | LYS A 17GLY A 18ARG A 19ASN A 205HIS A 206TYR A 252 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)SFG A 491 (-3.9A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) | 0.55A | 5tegB-3n71A:7.85tegE-3n71A:undetectable | 5tegB-3n71A:15.045tegE-3n71A:8.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Mus musculus) |
PF00856(SET)PF01753(zf-MYND) | 5 | LYS A 17LEU A 21ASN A 205HIS A 206TYR A 252 | SFG A 491 (-4.7A)NoneSFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) | 1.19A | 5tegB-3n71A:7.85tegE-3n71A:undetectable | 5tegB-3n71A:15.045tegE-3n71A:8.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 5 | GLY A 102TYR A 146ASN A 169HIS A 170TYR A 207 | SAM A 237 ( 3.7A)SAM A 237 (-4.1A)SAM A 237 (-3.3A)SAM A 237 (-4.7A)None | 0.35A | 5tegB-3ooiA:14.35tegE-3ooiA:undetectable | 5tegB-3ooiA:23.535tegE-3ooiA:4.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 6 | LYS A2150GLY A2151TYR A2194ASN A2217HIS A2218TYR A2255 | NoneSAM A 7 (-3.4A)SAM A 7 (-3.4A)SAM A 7 (-3.9A)NoneNone | 0.46A | 5tegB-3opeA:14.35tegE-3opeA:undetectable | 5tegB-3opeA:22.875tegE-3opeA:5.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rc0 | N-LYSINEMETHYLTRANSFERASESETD6 (Homo sapiens) |
PF00856(SET)PF09273(Rubis-subs-bind) | 5 | GLY A 74TYR A 223ASN A 251HIS A 252TYR A 285 | SAM A 484 (-3.4A)SAM A 484 (-3.6A)SAM A 484 (-3.1A)NoneSAM A 484 (-4.8A) | 0.79A | 5tegB-3rc0A:5.15tegE-3rc0A:undetectable | 5tegB-3rc0A:15.325tegE-3rc0A:2.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fmu | HISTONE-LYSINEN-METHYLTRANSFERASESETD2 (Homo sapiens) |
PF00856(SET) | 5 | LYS A1560GLY A1561TYR A1605ASN A1628HIS A1629 | None0UM A1804 (-3.5A)0UM A1804 (-4.2A)0UM A1804 (-3.3A)None | 0.42A | 5tegB-4fmuA:13.65tegE-4fmuA:undetectable | 5tegB-4fmuA:23.605tegE-4fmuA:4.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ldg | PROTEIN WITH A SETDOMAIN WITHINCARBOXY REGION (Cryptosporidiumparvum) |
PF00856(SET) | 5 | GLY A 149TYR A 193LEU A 220ASN A 222HIS A 223 | None | 0.92A | 5tegB-4ldgA:15.95tegE-4ldgA:undetectable | 5tegB-4ldgA:30.585tegE-4ldgA:5.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ldg | PROTEIN WITH A SETDOMAIN WITHINCARBOXY REGION (Cryptosporidiumparvum) |
PF00856(SET) | 5 | TYR A 193LEU A 220ASN A 222HIS A 223TYR A 261 | None | 1.02A | 5tegB-4ldgA:15.95tegE-4ldgA:undetectable | 5tegB-4ldgA:30.585tegE-4ldgA:5.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qeo | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFICSUVH4 (Arabidopsisthaliana) |
PF00856(SET)PF02182(SAD_SRA)PF05033(Pre-SET) | 6 | LYS A 456GLY A 457TYR A 493ASN A 551HIS A 552TYR A 593 | SAH A 801 (-4.7A)SAH A 801 (-3.6A)SAH A 801 (-4.0A)SAH A 801 (-3.2A)NoneNone | 0.56A | 5tegB-4qeoA:8.95tegE-4qeoA:undetectable | 5tegB-4qeoA:16.215tegE-4qeoA:1.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z4p | HISTONE-LYSINEN-METHYLTRANSFERASE2D (Homo sapiens) |
PF00856(SET) | 5 | GLY A5408TYR A5451ASN A5474HIS A5475TYR A5512 | SAH A5602 (-3.6A)SAH A5602 (-4.5A)SAH A5602 (-3.1A)NoneNone | 0.57A | 5tegB-4z4pA:16.05tegE-4z4pA:undetectable | 5tegB-4z4pA:28.985tegE-4z4pA:12.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f59 | HISTONE-LYSINEN-METHYLTRANSFERASE2C (Homo sapiens) |
PF00856(SET) | 5 | GLY A4782TYR A4825ASN A4848HIS A4849TYR A4886 | SAH A5002 (-3.5A)SAH A5002 (-4.5A)SAH A5002 (-2.7A)SAH A5002 (-4.6A)None | 0.78A | 5tegB-5f59A:15.95tegE-5f59A:undetectable | 5tegB-5f59A:29.525tegE-5f59A:18.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5f6l | HISTONE-LYSINEN-METHYLTRANSFERASE2A (Homo sapiens) |
PF00856(SET) | 5 | GLY A3840TYR A3883ASN A3906HIS A3907TYR A3944 | SAH A4001 (-3.4A)NoneSAH A4001 (-3.0A)SAH A4001 (-4.9A)SAH A4001 (-4.9A) | 0.54A | 5tegB-5f6lA:17.05tegE-5f6lA:undetectable | 5tegB-5f6lA:35.335tegE-5f6lA:4.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homo sapiens) |
PF00856(SET)PF01753(zf-MYND) | 6 | LYS A 17GLY A 18ARG A 19ASN A 206HIS A 207TYR A 240 | NoneSAM A 501 ( 4.1A)SAM A 501 (-3.7A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) | 0.77A | 5tegB-5kjmA:8.65tegE-5kjmA:undetectable | 5tegB-5kjmA:17.035tegE-5kjmA:5.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homo sapiens) |
PF00856(SET)PF01753(zf-MYND) | 6 | LYS A 17GLY A 18LEU A 204ASN A 206HIS A 207TYR A 240 | NoneSAM A 501 ( 4.1A)NoneSAM A 501 (-3.2A)None6TM A 502 ( 3.6A) | 0.90A | 5tegB-5kjmA:8.65tegE-5kjmA:undetectable | 5tegB-5kjmA:17.035tegE-5kjmA:5.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lsu | HISTONE-LYSINEN-METHYLTRANSFERASENSD2 (Homo sapiens) |
PF00856(SET) | 5 | GLY A1074TYR A1118ASN A1141HIS A1142TYR A1179 | SAM A1304 ( 3.2A)SAM A1304 (-3.8A)SAM A1304 (-2.9A)SAM A1304 (-4.6A)SAM A1304 (-4.1A) | 0.24A | 5tegB-5lsuA:13.85tegE-5lsuA:undetectable | 5tegB-5lsuA:24.155tegE-5lsuA:4.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5teg | N-LYSINEMETHYLTRANSFERASEKMT5A (Homo sapiens) |
PF00856(SET) | 9 | LYS A 226GLY A 227ARG A 228TYR A 271LEU A 296ASN A 298HIS A 299TYR A 336TRP A 349 | SAM A 401 (-4.6A)SAM A 401 ( 4.0A)SAM A 401 (-3.7A)SAM A 401 (-4.1A)SAM A 401 (-4.6A)SAM A 401 (-3.2A)NoneSAM A 401 (-4.8A)SAM A 401 (-3.7A) | 0.14A | 5tegB-5tegA:28.05tegE-5tegA:undetectable | 5tegB-5tegA:100.005tegE-5tegA:4.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A1049TYR A1085ASN A1112HIS A1113TYR A1154 | SAM A1505 ( 3.9A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A) | 0.23A | 5tegB-5tuyA:12.85tegE-5tuyA:undetectable | 5tegB-5tuyA:23.385tegE-5tuyA:4.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A1137TYR A1173ASN A1200HIS A1201TYR A1242 | SAM A3001 (-3.6A)SAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A) | 0.24A | 5tegB-5vsdA:13.85tegE-5vsdA:undetectable | 5tegB-5vsdA:23.995tegE-5vsdA:3.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xxg | - (-) |
no annotation | 5 | GLY A 15LEU A 203ASN A 205HIS A 206TYR A 239 | SAM A 502 ( 3.9A)NoneSAM A 502 (-3.1A)None8HR A 501 ( 4.0A) | 0.51A | 5tegB-5xxgA:7.75tegE-5xxgA:undetectable | 5tegB-5xxgA:undetectable5tegE-5xxgA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cen | HISTONE-LYSINEN-METHYLTRANSFERASENSD3 (Homo sapiens) |
no annotation | 5 | GLY A1156TYR A1200ASN A1223HIS A1224TYR A1261 | SAM A1301 (-3.6A)SAM A1301 (-3.9A)SAM A1301 (-3.2A)NoneSAM A1301 (-4.9A) | 0.26A | 5tegB-6cenA:14.35tegE-6cenA:undetectable | 5tegB-6cenA:undetectable5tegE-6cenA:undetectable |